Skip to main content
Premium Trial:

Request an Annual Quote

People in the News: Charles Abdalian

Premium

BG Medicine has appointed Charles Abdalian to executive vice president and chief financial officer. He joins the company from Knome, where he served as chief financial officer.

He is replacing Michael Rogers, who is leaving the company.

Previously, Abdalian was senior vice president and chief financial officer of Molecular Insight Pharmaceuticals, senior vice president and chief financial officer at Coley Pharmaceutical Group, and president and CEO of Pelias Technologies.

He holds a BS in business administration from Norwich University and an MBA from the Wharton School of the University of Pennsylvania.

The Scan

Mosquitos Genetically Modified to Prevent Malaria Spread

A gene drive approach could be used to render mosquitos unable to spread malaria, researchers report in Science Advances.

Gut Microbiomes Allow Bears to Grow to Similar Sizes Despite Differing Diets

Researchers in Scientific Reports find that the makeup of brown bears' gut microbiomes allows them to reach similar sizes even when feasting on different foods.

Finding Safe Harbor in the Human Genome

In Genome Biology, researchers present a new approach to identify genomic safe harbors where transgenes can be expressed without affecting host cell function.

New Data Point to Nuanced Relationship Between Major Depression, Bipolar Disorder

Lund University researchers in JAMA Psychiatry uncover overlapping genetic liabilities for major depression and bipolar disorder.